This diagnostic study validates the biological comparability of brain amyloid thresholds used in AlzheimerDisease diagnostics across racial and ethnic subgroups of older adults, with no significant differences by sex or APOE4 status.

Further research should determine whether uniform thresholds yield comparable prognostic utility in clinical practice.